Home/Pipeline/iFOB

iFOB

Colorectal Cancer Screening

CommercialActive

Key Facts

Indication

Colorectal Cancer Screening

Phase

Commercial

Status

Active

Company

Pangea Laboratory

About Pangea Laboratory

Pangea Laboratory is a U.S.-based diagnostic services company founded in 2019, operating a high-complexity clinical lab. It provides end-to-end NGS services from R&D through commercialization, serving as a development and reference lab partner. The company has a growing menu of proprietary non-invasive tests, including an FDA Breakthrough Device-designated assay for bladder cancer, and is expanding into microbiome and infectious disease diagnostics. Its business model combines fee-for-service lab work with the development and launch of its own diagnostic products.

View full company profile

Therapeutic Areas

Oncology Infectious Disease

Other Colorectal Cancer Screening Drugs

Drug	Company	Phase	Status
Shield (ECLIPSE Study)	Guardant Health	FDA Approved	Commercial
Urine cfDNA Test for Colon Cancer Screening	JBS Science	Development	Active
ColoHealth	New Day Diagnostics	Approved	Active
CRC Screening Program	Polymedco	Commercial	Active
SimpleScreen CRC	Freenome	Commercial (as LDT)	Active
ColoScape™ / QuantiDNA™	DiaCarta	Commercial	Active
ColoSense	Geneoscopy	Approved	Active
At-Home Colorectal Cancer Screening	SNT Biotech	Commercial	Active
FIT System & Assay Development	Sentinel Diagnostics	Commercial	Active
Next-Generation Cologuard®	Exact Sciences	Development	Active
ColoAlert®	Mainz Biomed	Pivotal Trial	Active (ReconAAsense FDA trial)